Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Shares Outstanding (Weighted Average): 2020-2024

Historic Shares Outstanding (Weighted Average) for Candel Therapeutics (CADL) over the last 5 years, with Dec 2024 value amounting to $32.5 million.

  • Candel Therapeutics' Shares Outstanding (Weighted Average) rose 0.09% to $28.9 million in Q4 2023 from the same period last year, while for Sep 2023 it was $28.9 million, marking a year-over-year increase of 0.10%. This contributed to the annual value of $32.5 million for FY2024, which is 12.30% up from last year.
  • According to the latest figures from FY2024, Candel Therapeutics' Shares Outstanding (Weighted Average) is $32.5 million, which was up 12.30% from $28.9 million recorded in FY2023.
  • Candel Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $32.5 million during FY2024, with a 5-year trough of $24.8 million in FY2020.
  • In the last 3 years, Candel Therapeutics' Shares Outstanding (Weighted Average) had a median value of $28.9 million in 2023 and averaged $30.1 million.
  • Data for Candel Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 15.70% (in 2021) over the last 5 years.
  • Candel Therapeutics' Shares Outstanding (Weighted Average) (Yearly) stood at $24.8 million in 2020, then rose by 15.70% to $28.7 million in 2021, then rose by 0.71% to $28.9 million in 2022, then climbed by 0.09% to $28.9 million in 2023, then climbed by 12.30% to $32.5 million in 2024.